Cargando…
Fusogenic-Oligoarginine Peptide-Mediated Delivery of siRNAs Targeting the CIP2A Oncogene into Oral Cancer Cells
Despite a better understanding of the pathogenesis of oral cancer, its treatment outcome remains poor. Thus, there is a need for new therapeutic strategies to improve the prognosis of this disease. RNA interference (RNAi) appears to be a promising therapeutic tool for the treatment of many diseases,...
Autores principales: | Cantini, Liliana, Attaway, Christopher C., Butler, Betsy, Andino, Lourdes M., Sokolosky, Melissa L., Jakymiw, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3760901/ https://www.ncbi.nlm.nih.gov/pubmed/24019920 http://dx.doi.org/10.1371/journal.pone.0073348 |
Ejemplares similares
-
Identification and characterization of Dicer1e, a Dicer1 protein variant, in oral cancer cells
por: Cantini, Liliana P, et al.
Publicado: (2014) -
In Vitro Cellular Uptake and Transfection of Oligoarginine-Conjugated Glycol Chitosan/siRNA Nanoparticles
por: Jeong, Eun-Ju, et al.
Publicado: (2021) -
Fusogenic peptide delivery of bioactive siRNAs targeting CSNK2A1 for treatment of ovarian cancer
por: Samec, Timothy, et al.
Publicado: (2022) -
A database of breast oncogenic specific siRNAs
por: Tyagi, Atul, et al.
Publicado: (2017) -
Selective DNA Delivery to Tumor Cells Using an Oligoarginine-LTVSPWY Peptide
por: Gong, Cheng, et al.
Publicado: (2014)